Match tier Listed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-10-08

Mattie R Nester

Role not yet determined Is this you? Add your title

UAMS
1 h-index 8 pubs 3 cited

Research Areas

Biomedical Subjects

  • Receptor, Notch3
  • Multiple Myeloma
  • Drug Resistance, Neoplasm
  • Animals
  • Antineoplastic Agents
  • Disease Models, Animal
  • Humans
  • Signal Transduction
  • Xenograft Model Antitumor Assays
  • Cell Line, Tumor
  • Mice

OverviewAI-generated summary

Mattie R. Nester's research focuses on understanding and targeting mechanisms of multiple myeloma, a cancer of plasma cells. Nester has investigated the role of the NOTCH3 receptor in eradicating dormant and therapy-resistant multiple myeloma cells. This work involves studying signal transduction pathways and potential therapeutic strategies. Additionally, Nester's publications include work on restoring bone health in multiple myeloma through sclerostin inhibition and improving dementia risk factor knowledge in rural older adults. Nester collaborates with researchers Japneet Kaur, Elena Ambrogini, Bethany C. Paxton, and Sharmin Khan at the University of Arkansas for Medical Sciences, with whom Nester has co-authored multiple publications.

Metrics

  • h-index: 1
  • Publications: 8
  • Citations: 3

Selected Publications

  • Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells (2026)
    Figshare DOI OpenAlex
  • Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells (2026)
    Figshare DOI OpenAlex
  • Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells (2026)
    Figshare DOI OpenAlex
  • Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells (2026)
    Figshare DOI OpenAlex
  • Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells (2026)
    Journal of Experimental & Clinical Cancer Research DOI OpenAlex
  • Healing of lytic lesions and restoration of bone health in multiple myeloma through sclerostin inhibition (2025)
    Experimental Hematology and Oncology 3 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

35 Collaborators 9 Institutions 3 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics

Monica Graziutti University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments Receptor Mechanisms and Signaling Cancer Treatment and Pharmacology
Good match 3 shared topics
Kenya Eddings University of Arkansas for Medical Sciences
Receptor Mechanisms and Signaling Disease Models, Animal Drug Transport and Resistance Mechanisms
Related 3 shared topics
Pritam Saha Podder University of Arkansas for Medical Sciences
Receptor Mechanisms and Signaling Cancer Treatment and Pharmacology Disease Models, Animal
Related 3 shared topics
Hayley M. Sabol University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments Receptor Mechanisms and Signaling Cancer Treatment and Pharmacology
Related 3 shared topics
Silvia Marino University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments Receptor Mechanisms and Signaling Disease Models, Animal
Related 3 shared topics
Bethany C. Paxton University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments Receptor Mechanisms and Signaling Drug Transport and Resistance Mechanisms
Related 3 shared topics